TEVA insider transaction filings
TEVA PHARMACEUTICAL INDUSTRIES LTD — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-25. Screen TEVA transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 6 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 6 filings by 6 insiders — 66,882 shares, $2,391,045 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 25,578 shares @ $34.88 ($892,051) by Hughes Eric A, filed 2026-08-05.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Hughes Eric A — See "Remarks" | 1 | — | 1 leg · 25,578 sh · $892,051 | 2 |
| Lippman Evan — EVP, Business Development | 1 | — | 1 leg · 18,600 sh · $680,291 | — |
| Jover Placid — See "Remarks" | 1 | — | 1 leg · 12,827 sh · $447,351 | 2 |
| Weiss Amir — Chief Accounting Officer | 1 | — | 2 legs · 9,445 sh · $355,301 | 2 |
| Satchi-Fainaro Ronit — Director | 1 | — | 1 leg · 415 sh · $15,459 | — |
| Zaks Tal Zvi — Director | 1 | — | 1 leg · 17 sh · $593 | — |
Recent Form 4 filings — TEVA PHARMACEUTICAL INDUSTRIES LTD
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-25 | 4 | Satchi-Fainaro Ronit — Director | Sale (S): 415 @ $37.25 | EDGAR |
| 2026-08-25 | 4 | Weiss Amir — Chief Accounting Officer | Sale (S): 6,945 @ $37.61 · Option exercise (M): 2,500 @ $19.61 · Sale (S): 2,500 @ $37.63 · Option exercise (M): 2,500 (derivative) @ $19.16 | EDGAR |
| 2026-08-19 | 4 | Lippman Evan — EVP, Business Development | Sale (S): 18,600 @ $36.57 | EDGAR |
| 2026-08-10 | 4 | Zaks Tal Zvi — Director | Sale (S): 17 @ $34.87 | EDGAR |
| 2026-08-05 | 4 | Jover Placid — See "Remarks" | Option exercise (M): 12,827 · Sale (S): 12,827 @ $34.88 · Option exercise (M): 12,827 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Hughes Eric A — See "Remarks" | Option exercise (M): 52,744 · Sale (S): 25,578 @ $34.88 · Option exercise (M): 52,744 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Shields Matthew — EVP, Global Operations | Sale (S): 9,989 @ $32.19 | EDGAR |
| 2026-06-16 | 4 | Kalif Eliyahu Sharon — EVP, Chief Financial Officer | Sale (S): 106,563 @ $34.10 | EDGAR |
| 2026-06-08 | 4 | Lichtenstein Chen — Director | Option exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Satchi-Fainaro Ronit — Director | Option exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Elstein Amir — Director | Option exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Zaks Tal Zvi — Director | Option exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Nisen Perry — Director | Option exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Francis Richard D — President and CEO | Option exercise (M): 13,043 · Sale (S): 6,153 @ $34.35 · Option exercise (M): 13,043 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Crane Rosemary A — Director | Option exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | MIGNONE ROBERTO — Director | Option exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | BARER SOL J — Director | Option exercise (M): 21,739 · Option exercise (M): 21,739 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | LIEBERMAN GERALD M — Director | Option exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Shields Matthew — EVP, Global Operations | Option exercise (M): 16,195 · Sale (S): 16,195 @ $32.87 · Option exercise (M): 16,195 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Lichtenstein Chen — Director | Grant/award (A): 7,242 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Satchi-Fainaro Ronit — Director | Grant/award (A): 7,242 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Elstein Amir — Director | Grant/award (A): 7,242 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Zaks Tal Zvi — Director | Grant/award (A): 7,242 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Nisen Perry — Director | Grant/award (A): 7,242 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Crane Rosemary A — Director | Grant/award (A): 7,242 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | MIGNONE ROBERTO — Director | Grant/award (A): 7,242 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | BARER SOL J — Director | Grant/award (A): 10,863 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | LIEBERMAN GERALD M — Director | Grant/award (A): 7,242 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Lippman Evan — EVP, Business Development | Option exercise (M): 11,841 · Sale (S): 5,746 @ $35.58 · Option exercise (M): 74,008 · Sale (S): 35,912 @ $35.58 · Option exercise (M): 11,841 (derivative) @ $0 · Option exercise (M): 74,008 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Kalif Eliyahu Sharon — EVP, Chief Financial Officer | Sale (S): 153,251 @ $35.61 | EDGAR |
| 2026-05-07 | 4 | Weiss Amir — Chief Accounting Officer | Sale (S): 10,679 @ $36 | EDGAR |
| 2026-05-07 | 4 | Daniell Richard — EVP, Europe Commercial | Sale (S): 30,000 @ $35.40 | EDGAR |
| 2026-05-04 | 4 | Fox Christine — EVP, U.S. Commercial | Sale (S): 21,258 @ $35.31 | EDGAR |
| 2026-05-04 | 4 | Sabag Mark — See "Remarks" | Sale (S): 144,180 @ $34.99 | EDGAR |
| 2026-03-19 | 4 | Sabag Mark — See "Remarks" | Sale (S): 62,102 @ $30.14 | EDGAR |
| 2026-03-09 | 4 | Savage Brian — Interim Chief Legal Officer | Option exercise (M): 3,580 · Sale (S): 1,127 @ $31.67 · Option exercise (M): 3,580 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Jover Placid — See "Remarks" | Option exercise (M): 14,150 · Sale (S): 14,150 @ $31.67 · Option exercise (M): 14,150 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Shields Matthew — EVP, Global Operations | Option exercise (M): 17,295 · Sale (S): 17,295 @ $31.67 · Option exercise (M): 17,295 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Fox Christine — EVP, U.S. Commercial | Option exercise (M): 17,819 · Sale (S): 7,924 @ $31.67 · Option exercise (M): 17,819 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Hughes Eric A — See "Remarks" | Option exercise (M): 19,654 · Sale (S): 9,533 @ $31.67 · Option exercise (M): 19,654 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Weiss Amir — Chief Accounting Officer | Option exercise (M): 3,537 · Option exercise (M): 3,537 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Kalif Eliyahu Sharon — EVP, Chief Financial Officer | Option exercise (M): 19,916 · Option exercise (M): 19,916 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Daniell Richard — EVP, Europe Commercial | Option exercise (M): 17,295 · Sale (S): 17,295 @ $31.67 · Option exercise (M): 17,295 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Sabag Mark — See "Remarks" | Option exercise (M): 15,723 · Option exercise (M): 15,723 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Francis Richard D — President and CEO | Option exercise (M): 42,452 · Sale (S): 20,025 @ $31.67 · Option exercise (M): 42,452 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Weiss Amir — Chief Accounting Officer | Option exercise (M): 10,679 · Option exercise (M): 5,650 · Option exercise (M): 10,679 (derivative) @ $0 · Option exercise (M): 5,650 (derivative) @ $0 · Grant/award (A): 11,280 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Kalif Eliyahu Sharon — EVP, Chief Financial Officer | Option exercise (M): 33,512 · Option exercise (M): 23,251 · Option exercise (M): 33,512 (derivative) @ $0 · Option exercise (M): 23,251 (derivative) @ $0 · Grant/award (A): 53,175 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Daniell Richard — EVP, Europe Commercial | Option exercise (M): 33,512 · Sale (S): 33,512 @ $32.46 · Option exercise (M): 20,461 · Sale (S): 20,461 @ $32.46 · Sale (S): 37,372 @ $32.95 · Option exercise (M): 33,512 (derivative) @ $0 · +2 more | EDGAR |
| 2026-03-06 | 4 | Sabag Mark — See "Remarks" | Option exercise (M): 33,512 · Option exercise (M): 18,601 · Option exercise (M): 33,512 (derivative) @ $0 · Option exercise (M): 18,601 (derivative) @ $0 · Grant/award (A): 30,385 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Francis Richard D — President and CEO | Option exercise (M): 50,223 · Sale (S): 23,393 @ $32.46 · Option exercise (M): 50,223 (derivative) @ $0 · Grant/award (A): 136,736 (derivative) @ $0 | EDGAR |
Recent 8-K events — TEVA PHARMACEUTICAL INDUSTRIES LTD
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-16 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-14 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-09-11 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-03 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-03 | 8-K | 3.03 — Material Modification to Rights of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-29 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-28 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-29 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-28 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TEVA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →